DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020
May 19 2020 - 3:42PM
Business Wire
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that
it will be participating in the 17th Annual Craig-Hallum
Institutional Investor Conference being held virtually on
Wednesday, May 27, 2020. Management will be available to
participate in one-on-one meetings. Meetings will take place
virtually given the ongoing call for social distancing due to the
Covid-19 pandemic. Investors and attendees that would like to
schedule a meeting with DiaMedica’s management can contact their
Craig-Hallum representative to arrange a meeting.
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a clinical stage
biopharmaceutical company focused on developing novel treatments
for chronic kidney diseases and neurological disorders. The Company
recently released positive top-line results from its phase II study
in acute ischemic stroke and has a phase II study ongoing in
chronic kidney disease. DiaMedica’s shares are listed on The Nasdaq
Capital Market under the trading symbol “DMAC.”
For more information, please visit www.diamedica.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200519005684/en/
Scott Kellen Chief Financial Officer Phone: (763) 496-5118
skellen@diamedica.com
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Apr 2024 to May 2024
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From May 2023 to May 2024